HuMax-CD20 in Chronic Lymphocytic Leukemia

This study has been completed.
Information provided by Genmab

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Chronic Lymphocytic Leukemia
2		Additional conditions recognized in this trial
			Leukemia
			Leukemia, B-Cell
			Leukemia, Lymphocytic, Chronic, B-Cell
			Leukemia, Lymphoid
3		More general conditions related to this trial
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphatic Diseases
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
4		Interventions listed in this trial
			HuMax-CD20
5		Sponsors listed in this trial
			Genmab